Chambers Seminar: Healthcare

Challenges and Opportunities in Healthcare

 

This session will be led by Jingtian & Gongcheng and will be held in Chinese

 

Time: 11:30 – 13:00

 

Part I: The Opportunities and Challenges of the Genetic Industry in China

- The Current Legal Regime:An Overview of Regulatory Supervision of the Genetic Industry and Foreign Investment Control in Specific Areas
- Legal Practices:Discussion on the Challenges Related to Investment, Acquisition, and the Operation of Genetic Testing Laboratories in China 

 

Part II: Analysis of IPO Competition among Innovative Drug R&D Companies - Case Studies of the Causes and Solutions of Competition among Innovative Drug R&D Companies  

 

Part III: Risk Response and Strategic Planning of Intellectual Property and Antitrust for Companies in Life Sciences Companies

- An overview of intellectual property protection strategies for pharmaceutical enterprises, using pharmaceutical crystallization patent as a case study
- Intellectual property and anti-monopoly risks of reverse payment of pharmaceutical enterprises 
- Intellectual property rights and anti-monopoly risks of product hopping

 

Q&A and Discussion  

 

Speakers

 

Wei Ren
Partner
Jingtian & Gongcheng

Mr. Ren focuses on health care, pharmaceuticals and life sciences legal practices. He has served a large number of clients throughout their listing projects in mainland China, Hong Kong, Singapore and the US. He also actively helps clients with their investment, bond issuance and M&A deals in medical and health

 

Ye Zhao
Partner
Jingtian & Gongcheng

Mr. Zhao practices in the field of intellectual property litigation and intellectual property antitrust in China with a particular focus on disputes in telecommunication, semi-conductor and the pharmaceutical sectors. Mr. Zhao has represented clients in a number of landmark cases in China, including Intel Corporation and Huawei Technology Co., Ltd.  Mr. Zhao was an invited keynote speaker on Standard Essential Patent by the American Bar Association in its 2018 ABA SIL Seoul Conference

 

Hanshuo Zhou
Partner
Jingtian & Gongcheng

Ms. Zhou specialises in life sciences and healthcare legal practices. Her clients range from traditional pharmaceutical and medical devices companies to upcoming gene testing laboratories, medical data management, bio-technology, immunotherapy treatment companies and R&D centers.  She also assists domestic and international PE/VC funds in their investments in life science and healthcare portfolios